Literature DB >> 9794129

Penicillin resistance in laboratory isolates of Streptococcus pneumoniae, in Western Australia, 1990-1994.

V A McLaughlin1, T V Riley, C L Roberts.   

Abstract

Increasing frequency of penicillin resistance in Streptococcus pneumoniae has been reported worldwide. We report on clinical isolates of penicillin-resistant pneumococci (PRP) in Western Australia (WA) from 1990-1994. A retrospective survey of laboratories performing susceptibility testing, or receiving isolates referred from rural areas found resistant on oxacillin disc screening, was undertaken. Four of 11 laboratories could provide data for the five year time period inclusive. Information was provided on susceptibility to penicillin, type of specimen, date of isolation and; age, sex and race of individuals with PRP. Penicillin resistance increased from 1.3% to 9.0% over the five year period. PRP were rarely invasive. Highest age specific rates per 100,000 were found in children < 5 years (19.4) and adults > or = 60 years (5.1). Aboriginal ethnicity was associated with resistance. The increasing frequency of PRP in WA indicates the need for surveillance systems for their detection.

Entities:  

Mesh:

Year:  1998        PMID: 9794129     DOI: 10.1023/a:1007446304166

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  Invasive pneumococcal disease in central Australia.

Authors:  R A McDermott; W M Williams
Journal:  Med J Aust       Date:  1995-05-15       Impact factor: 7.738

Review 2.  Pathogenesis of pneumococcal infection.

Authors:  E I Tuomanen; R Austrian; H R Masure
Journal:  N Engl J Med       Date:  1995-05-11       Impact factor: 91.245

3.  Pneumococci relatively insensitive to penicillin in Australia and New Guinea.

Authors:  D Hansman; L Devitt; H Miles; I Riley
Journal:  Med J Aust       Date:  1974-09-07       Impact factor: 7.738

4.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

Authors:  V A Arason; K G Kristinsson; J A Sigurdsson; G Stefánsdóttir; S Mölstad; S Gudmundsson
Journal:  BMJ       Date:  1996-08-17

5.  Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.

Authors:  R Manninen; P Huovinen; A Nissinen
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

Review 6.  Invasive pneumococcal disease in central Australia.

Authors:  P J Torzillo; J N Hanna; F Morey; M Gratten; J Dixon; J Erlich
Journal:  Med J Aust       Date:  1995-02-20       Impact factor: 7.738

7.  Streptococcus pneumoniae carriage and penicillin/ceftriaxone resistance in hospitalised children in Darwin.

Authors:  S A Skull; A J Leach; B J Currie
Journal:  Aust N Z J Med       Date:  1996-06

Review 8.  Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study.

Authors:  T Q Tan; E O Mason; S L Kaplan
Journal:  Pediatrics       Date:  1993-12       Impact factor: 7.124

9.  Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia.

Authors:  M R Reichler; J Rakovsky; A Sobotová; M Sláciková; B Hlavácová; B Hill; L Krajcíková; P Tarina; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

10.  The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio.

Authors:  M R Reichler; A A Allphin; R F Breiman; J R Schreiber; J E Arnold; L K McDougal; R R Facklam; B Boxerbaum; D May; R O Walton
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

View more
  1 in total

1.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.